Dr. Nemechek has noticed that once his patient’s began demonstrating recovery of autonomic function, they also began experiencing recovery from other neuroinflammatory disorders such as attention deficit disorder, chronic anxiety, macular degeneration, central retinal vein thrombosis, chronic depression, post traumatic stress disorders, and chronic fatigue syndrome.
Autonomic recovery is now used by Dr. Nemechek as a surrogate biomarker of neuroinflammatory recovery. In medicine, a biomarker is an indirect indicator of a disease state or its response to treatment. An example of this is the measurement of blood sugar to monitor the severity of diabetes mellitus or the use of blood pressure monitoring to manage hypertension.
When treating brain injuries, autonomic recovery is a biomarker informing us that neuroinflammation has been reduced enough to allow re-activation of the normal repair process. Sequential testing of the autonomic testing can easily detect the recovery of brain function, and is followed over time to insure that treatment remains effective.
Once re-activated, the reparative process reverses not only damage to the autonomic nervous system but to other areas within the brain. The broad level of recovery is can be seen with reversal of depression, PTSD, anxiety, and improved motor function and coordination.